These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9434720

  • 21. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
    Larrat S, Morand P, Bas A, Vigne S, Crance JM, Boyer V, Nicod S, Grossi L, Buisson M, Burmeister WP, Seigneurin JM, Germi R.
    Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
    [Abstract] [Full Text] [Related]

  • 22. Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.
    Park R, Heston L, Shedd D, Delecluse HJ, Miller G.
    Virology; 2008 Dec 20; 382(2):145-62. PubMed ID: 18937960
    [Abstract] [Full Text] [Related]

  • 23. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.
    PLoS Pathog; 2007 Jun 20; 3(6):e80. PubMed ID: 17559303
    [Abstract] [Full Text] [Related]

  • 24. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K, Roubal J, Vonka V, Brichácek B, Reifová M.
    Acta Virol; 1983 Jul 20; 27(4):329-36. PubMed ID: 6138996
    [Abstract] [Full Text] [Related]

  • 25. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.
    Gershburg E, Pagano JS.
    J Virol; 2002 Feb 20; 76(3):998-1003. PubMed ID: 11773375
    [Abstract] [Full Text] [Related]

  • 26. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov 20; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 27. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W, Binné UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ.
    J Virol; 2004 Dec 20; 78(24):13460-9. PubMed ID: 15564457
    [Abstract] [Full Text] [Related]

  • 28. Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells.
    Kiehl A, Dorsky DI.
    Virology; 1991 Sep 20; 184(1):330-40. PubMed ID: 1651595
    [Abstract] [Full Text] [Related]

  • 29. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH.
    J Med Virol; 2004 Aug 20; 73(4):574-82. PubMed ID: 15221902
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.
    Liao G, Huang J, Fixman ED, Hayward SD.
    J Virol; 2005 Jan 20; 79(1):245-56. PubMed ID: 15596820
    [Abstract] [Full Text] [Related]

  • 34. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS, Bertoni G, Takagi S, Sairenji T.
    Virology; 1993 May 20; 194(1):387-92. PubMed ID: 8386883
    [Abstract] [Full Text] [Related]

  • 35. A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis.
    Narita Y, Sugimoto A, Kawashima D, Watanabe T, Kanda T, Kimura H, Tsurumi T, Murata T.
    Sci Rep; 2015 Jun 30; 5():11767. PubMed ID: 26123572
    [Abstract] [Full Text] [Related]

  • 36. The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex.
    Fujii K, Yokoyama N, Kiyono T, Kuzushima K, Homma M, Nishiyama Y, Fujita M, Tsurumi T.
    J Virol; 2000 Mar 30; 74(6):2550-7. PubMed ID: 10684269
    [Abstract] [Full Text] [Related]

  • 37. Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.
    Su MT, Liu IH, Wu CW, Chang SM, Tsai CH, Yang PW, Chuang YC, Lee CP, Chen MR.
    J Virol; 2014 Aug 30; 88(16):8883-99. PubMed ID: 24872582
    [Abstract] [Full Text] [Related]

  • 38. Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90.
    Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T.
    J Virol; 2013 Jun 30; 87(11):6482-91. PubMed ID: 23552409
    [Abstract] [Full Text] [Related]

  • 39. Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
    Drosu NC, Edelman ER, Housman DE.
    Proc Natl Acad Sci U S A; 2020 Jun 02; 117(22):12368-12374. PubMed ID: 32409608
    [Abstract] [Full Text] [Related]

  • 40. Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.
    Narita Y, Murata T, Ryo A, Kawashima D, Sugimoto A, Kanda T, Kimura H, Tsurumi T.
    J Virol; 2013 Feb 02; 87(4):2120-7. PubMed ID: 23221557
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.